Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Hwan Kim

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
Lung Cancer (Amsterdam, Netherlands)|March 18, 2014
Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutationsMin Hwan Kim, Hye Ryun Kim, Byoung Chul Cho, et al.
Cancers|July 2, 2021
Distinct Characteristics and Clinical Outcomes to Predict the Emergence of <i>MET</i> Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsBeung-Chul Ahn, Ji Hyun Lee, Min Hwan Kim, et al.
Breast Cancer Research and Treatment|December 8, 2019
Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and olderMin Hwan Kim, Gun Min Kim, Jee Hung Kim, et al.
The Oncologist|April 25, 2019
Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric CancerSu-Jin Shin, Sejung Park, Min Hwan Kim, et al.
Experimental & Molecular Medicine|April 15, 2024
Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradationSanghyun Park, Won-Ji Ryu, Tae Yeong Kim, et al.
Chemical & Pharmaceutical Bulletin|November 3, 2016
Development of HPLC Method for the Determination of Buspirone in Rat Plasma Using Fluorescence Detection and Its Application to a Pharmacokinetic StudyKi Taek Kim, Jae-Young Lee, Ju-Hwan Park, et al.
Clinical Breast Cancer|April 16, 2026
Subtype-Specific Risk and Temporal Dynamics of Brain Metastases in Metastatic Breast CancerKyoo Hyun Kim, Joohyuk Sohn, Min Hwan Kim, et al.
Breast Cancer Research and Treatment|July 15, 2020
Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancerAhrong Ham, Min Hwan Kim, Gun Min Kim, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Simple Methods for Tracking Stem Cells with (64)Cu-Labeled DOTA-hexadecyl-benzoateMin Hwan Kim, Sang-Keun Woo, Kwang Il Kim, et al.
Breast Cancer Research and Treatment|June 25, 2020
Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancerAhrong Ham, Min Hwan Kim, Gun Min Kim, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Lung Cancer (Amsterdam, Netherlands)|March 18, 2014
Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutationsMin Hwan Kim, Hye Ryun Kim, Byoung Chul Cho, et al.
Cancers|July 2, 2021
Distinct Characteristics and Clinical Outcomes to Predict the Emergence of <i>MET</i> Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsBeung-Chul Ahn, Ji Hyun Lee, Min Hwan Kim, et al.
Breast Cancer Research and Treatment|December 8, 2019
Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and olderMin Hwan Kim, Gun Min Kim, Jee Hung Kim, et al.
The Oncologist|April 25, 2019
Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric CancerSu-Jin Shin, Sejung Park, Min Hwan Kim, et al.
Experimental & Molecular Medicine|April 15, 2024
Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradationSanghyun Park, Won-Ji Ryu, Tae Yeong Kim, et al.
Chemical & Pharmaceutical Bulletin|November 3, 2016
Development of HPLC Method for the Determination of Buspirone in Rat Plasma Using Fluorescence Detection and Its Application to a Pharmacokinetic StudyKi Taek Kim, Jae-Young Lee, Ju-Hwan Park, et al.
Clinical Breast Cancer|April 16, 2026
Subtype-Specific Risk and Temporal Dynamics of Brain Metastases in Metastatic Breast CancerKyoo Hyun Kim, Joohyuk Sohn, Min Hwan Kim, et al.
Breast Cancer Research and Treatment|July 15, 2020
Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancerAhrong Ham, Min Hwan Kim, Gun Min Kim, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Simple Methods for Tracking Stem Cells with (64)Cu-Labeled DOTA-hexadecyl-benzoateMin Hwan Kim, Sang-Keun Woo, Kwang Il Kim, et al.
Breast Cancer Research and Treatment|June 25, 2020
Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancerAhrong Ham, Min Hwan Kim, Gun Min Kim, et al.
Pageof 12